132 related articles for article (PubMed ID: 26125839)
1. Positive association between PPARD rs2016520 polymorphism and coronary heart disease in a Han Chinese population.
Ye HD; Li YR; Hong QX; Zhou AN; Zhao QL; Xu LM; Xu MQ; Xu XT; Tang LL; Dai DJ; Jiang DJ; Huang Y; Wang DW; Duan SW
Genet Mol Res; 2015 Jun; 14(2):6350-9. PubMed ID: 26125839
[TBL] [Abstract][Full Text] [Related]
2. PPARD rs2016520 polymorphism and circulating lipid levels connect with brain diseases in Han Chinese and suggest sex-dependent effects.
Huang Y; Nie S; Zhou S; Li K; Sun J; Zhao J; Fei B; Wang Z; Ye H; Hong Q; Gao X; Duan S
Biomed Pharmacother; 2015 Mar; 70():7-11. PubMed ID: 25776471
[TBL] [Abstract][Full Text] [Related]
3. The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis.
Ding X; Han X; Yuan H; Zhang Y; Gao Y
Sci Rep; 2020 Mar; 10(1):5140. PubMed ID: 32198386
[TBL] [Abstract][Full Text] [Related]
4. Protective role of +294 T/C (rs2016520) polymorphism of PPARD in Mexican patients with colorectal cancer.
Rosales-Reynoso MA; Wence-Chavez LI; Arredondo-Valdez AR; Dumois-Petersen S; Barros-Núñez P; Gallegos-Arreola MP; Flores-Martínez SE; Sánchez-Corona J
Genet Mol Res; 2017 Jan; 16(1):. PubMed ID: 28128413
[TBL] [Abstract][Full Text] [Related]
5. PPARD rs2016520 polymorphism affects repaglinide response in Chinese Han patients with type 2 diabetes mellitus.
Song JF; Wang T; Zhu J; Zhou XY; Lu Q; Guo H; Zhang F; Wang Y; Li W; Wang DD; Cui YW; Lv DM; Yin XX
Clin Exp Pharmacol Physiol; 2015 Jan; 42(1):27-32. PubMed ID: 25311380
[TBL] [Abstract][Full Text] [Related]
6. PPARD rs2016520 polymorphism is associated with metabolic traits in a large population of Chinese adults.
Tang L; Lü Q; Cao H; Yang Q; Tong N
Gene; 2016 Jul; 585(2):191-5. PubMed ID: 26915488
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of the
Cao Y; Zhang Q; Chen J; Li Z; Zhou Z; Shen J; Wang D; Pan D; Wang Z; Ke D; Wang X; Lu D; Zhao Y; Cheng S; Shi Y
Hereditas; 2019; 156():15. PubMed ID: 31148953
[TBL] [Abstract][Full Text] [Related]
8. Association of peroxisome proliferator-activated receptor delta and additional gene-smoking interaction on cardiovascular disease.
Yang W; Mao S; Qu B; Zhang F; Xu Z
Clin Exp Hypertens; 2017; 39(2):114-118. PubMed ID: 28287878
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor delta +294T > C polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations.
Miao L; Yin RX; Wu DF; Cao XL; Li Q; Hu XJ; Yan TT; Aung LH; Yang DZ; Lin WX
Lipids Health Dis; 2010 Dec; 9():145. PubMed ID: 21176135
[TBL] [Abstract][Full Text] [Related]
10. Investigation of polymorphic variants of PPARD and APOE genes in Turkish coronary heart disease patients.
Yılmaz-Aydogan H; Kucukhuseyin O; Kurnaz O; Akadam-Teker B; Kurt O; Tekeli A; Ozturk O; Isbir T
DNA Cell Biol; 2012 May; 31(5):867-75. PubMed ID: 22277050
[TBL] [Abstract][Full Text] [Related]
11. PPARD rs2016520 (T/C) and NOS1AP rs12742393 (A/C) polymorphisms affect therapeutic efficacy of nateglinide in Chinese patients with type 2 diabetes mellitus.
Wang T; Song JF; Zhou XY; Li CL; Yin XX; Lu Q
BMC Med Genomics; 2021 Nov; 14(1):267. PubMed ID: 34772419
[TBL] [Abstract][Full Text] [Related]
12. The peroxisome proliferator-activated receptor delta +294T > C polymorphism and alcohol consumption on serum lipid levels.
Wei XL; Yin RX; Miao L; Wu DF
Lipids Health Dis; 2011 Dec; 10():242. PubMed ID: 22192471
[TBL] [Abstract][Full Text] [Related]
13. Minor alleles of
Zhang Y; Chen L; Zhu J; Liu H; Xu L; Wu Y; He C; Song Y
Front Endocrinol (Lausanne); 2023; 14():1249070. PubMed ID: 38161971
[TBL] [Abstract][Full Text] [Related]
14. Case-control study on association of peroxisome proliferator-activated receptor-δ and SNP-SNP interactions with essential hypertension in Chinese Han population.
Li Y; Sun G
Funct Integr Genomics; 2016 Jan; 16(1):95-100. PubMed ID: 26613934
[TBL] [Abstract][Full Text] [Related]
15. Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.
Qian Y; Li P; Zhang J; Shi Y; Chen K; Yang J; Wu Y; Ye X
Medicine (Baltimore); 2016 Aug; 95(32):e4299. PubMed ID: 27512842
[TBL] [Abstract][Full Text] [Related]
16. PPARD +294C overrepresentation in general and long-lived population in China Bama longevity area and unique relationships between PPARD +294T/C polymorphism and serum lipid profiles.
Luo CY; Liu CW; Ge L; Pang GF; Yang M; Hu CY; Lv ZP; Chen NY; Li HY; Wu HY; Wang YY; Yin RX; Pan SL; Peng JH
Lipids Health Dis; 2015 Mar; 14():17. PubMed ID: 25873088
[TBL] [Abstract][Full Text] [Related]
17. Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population.
Nikitin AG; Chistiakov DA; Minushkina LO; Zateyshchikov DA; Nosikov VV
Heart Vessels; 2010 May; 25(3):229-36. PubMed ID: 20512451
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral Polymorphism of Peroxisome Proliferator-Activated Receptor Delta-87 T>C in Colorectal Cancer.
Luo B; Yang HW; Long FW; Zhou B; Lv ZY; Cheng KL; Li Y; Zhou ZG; Sun XF
Neoplasma; 2019 Jul; 66(4):609-618. PubMed ID: 30868900
[TBL] [Abstract][Full Text] [Related]
19. Associations between hypertension and the peroxisome proliferator-activated receptor-δ (PPARD) gene rs7770619 C>T polymorphism in a Korean population.
Kim M; Kim M; Yoo HJ; Shon J; Lee JH
Hum Genomics; 2018 Jun; 12(1):28. PubMed ID: 29914579
[TBL] [Abstract][Full Text] [Related]
20. The association between peroxisome proliferator-activated receptor Δ rs3777744, rs3798343, and rs6922548 and coronary artery disease.
Zhang J; Liu XL; Jia QW; Zhao CH; Liu JY; An FH; Li LH; Chen ZH; Wang LS; Ma WZ; Yang ZJ; Jia EZ
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429241
[No Abstract] [Full Text] [Related]
[Next] [New Search]
